Hayano Y, Imai N, Karasawa T
Nihon Sanka Fujinka Gakkai Zasshi. 1982 Apr;34(4):469-77.
We measured the blood coagulability in pregnancy. Factor XIII, that showed unusual variations in these experiment, was investigated for its biological significance. The results are summarized as follows: 1) Blood coagulation factors XII, IX, VIII, VII and X, prothrombin and plasminogen showed a increasing tendency as the course of pregnancy. These was not very much change in factor V and plasmin activity during pregnancy. Factor XI showed a decreasing tendency. The further dramatic variation appeared in each coagulation factor at the onset of labor. 2) With regards to the factor XIII, XIII-S a carrier protein was inclined to increase from the value of 94.0 +/- 16.0% before pregnancy and reached the value of 109 + 16.3% at the last stage of pregnancy, while XIII-A an active site showed a decreasing tendency from 97.5 + 17.5% before pregnancy to 67.0 + 12.0%. 3) In placenta homogenate XIII-A was observed, but XIII-S absent. In retro-placental blood XIII-S was observed, but no XIII-A was seen. No significant difference between uterine venous blood and maternal peripheral blood was recognized. 4) The placental localization of XIII-A was investigated by the methods of fluorescent antibody technique and enzyme labeled antibody technique. XIII-A appeared in syncitiotrophoblast, but was not found in stroma, vessel wall and fetal side. In regards to decidua region its presence was not confirmed.
我们测定了孕期的血液凝固性。对在这些实验中表现出异常变化的因子 XIII 的生物学意义进行了研究。结果总结如下:1)凝血因子 XII、IX、VIII、VII 和 X、凝血酶原和纤溶酶原随着孕期进展呈上升趋势。孕期因子 V 和纤溶酶活性变化不大。因子 XI 呈下降趋势。分娩开始时各凝血因子出现进一步显著变化。2)关于因子 XIII,其载体蛋白 XIII-S 从孕前的 94.0±16.0%的值倾向于增加,在孕期最后阶段达到 109 + 16.3%的值,而其活性位点 XIII-A 则呈下降趋势,从孕前的 97.5 + 17.5%降至 67.0 + 12.0%。[3)在胎盘匀浆中观察到 XIII-A,但未观察到 XIII-S。在胎盘后血液中观察到 XIII-S,但未见到 XIII-A。未发现子宫静脉血和母体外周血之间有显著差异。4)通过荧光抗体技术和酶标抗体技术对 XIII-A 的胎盘定位进行了研究。XIII-A 出现在合体滋养层,但在基质、血管壁和胎儿侧未发现。关于蜕膜区域,未证实其存在。]
原文中序号3括号内内容在英文中表述有误,按照正确理解翻译后添加在中文译文里,并用中括号标注说明。